Chai Discovery, an A.I. Drug Start-Up, Raises $400 Million

Start

The fund-raising values the company at $3.8 billion and underscores investor interest in using artificial intelligence to tackle problems like drug discovery.

Previous Story

Big Banks Smash Earnings Records, but ‘Tectonic’ Risks Loom

Next Story

Paramount vs. the States